Citadel Advisors’s Mangoceuticals MGRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGRX
Citadel Advisors's MGRX Position: Q3 2026 in Review
Citadel Advisors reduced its Mangoceuticals (MGRX) stake by 44% in Q3 2026, selling an estimated $66.5K and leaving 189,004 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #13075.
Citadel Advisors first reported a position in MGRX in Q3 2023 and has held it in 6 quarters since. The position peaked at $129K in Q2 2026. 19 funds tracked by Wall St. Rank hold MGRX as of Q3 2026.
- Citadel Advisors held 189,004 shares of Mangoceuticals worth $80.9K as of Q3 2026.
- Citadel Advisors sold 149,960 Mangoceuticals shares in Q3 2026, an estimated $66.5K.
- Mangoceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13075 holding.
- Citadel Advisors first reported a position in Mangoceuticals in Q3 2023 and has held it in 6 quarters since.
- Citadel Advisors's Mangoceuticals position peaked at $129K in Q2 2026.
- 19 funds tracked by Wall St. Rank held Mangoceuticals as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.